Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The REBUILD Trial: A Prospective, Multi-Center, Single Arm Study Using REBUILD for Abdominal Wall Closure

NCT05687942 is registered in ClinicalTrials.gov with AbSolutions Med Inc. as lead sponsor.

NCT NCT05687942
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05687942 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The REBUILD Trial: A Prospective, Multi-Center, Single Arm Study Using REBUILD for Abdominal Wall Closure
Lead sponsor
AbSolutions Med Inc.
Phase
Not applicable
Overall status
Unknown status
Start date
March 31, 2023
Completion date
June 30, 2026
Enrollment
40 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

surgical incision